HCP (HCP) was Upgraded by Jefferies to ” Hold”. Earlier the firm had a rating of “Underperform ” on the company shares. Jefferies advised their investors in a research report released on May 10, 2016.
Many Wall Street Analysts have commented on HCP. UBS Downgraded HCP on Mar 16, 2016 to ” Neutral”, Price Target of the shares are set at $31.Shares were Reiterated by Barclays on Mar 10, 2016 to “Underweight” and Lowered the Price Target to $ 33 from a previous price target of $37 .Stifel Downgraded HCP on Feb 11, 2016 to ” Sell”, Price Target of the shares are set at $23.
On the company’s financial health, HCP reported $0.69 EPS for the quarter, based on the information available during the earnings call on May 9, 2016. Analyst had a consensus estimate of $0.69. The company had revenue of $640.80 million for the quarter, compared to analysts expectations of $613.89 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.79 EPS.
HCP opened for trading at $34.12 and hit $34.7 on the upside on Friday, eventually ending the session at $34.55, with a gain of 0.96% or 0.33 points. The heightened volatility saw the trading volume jump to 39,35,857 shares. Company has a market cap of $16,084 M.
In a different news, on Feb 17, 2016, John D. Stasinos (Executive Vice President) purchased 400 shares at $26.24 per share price. According to the SEC, on Feb 16, 2016, Troy E. Mchenry (EVP, Gen Counsel and Corp Sec) purchased 1,000 shares at $25.75 per share price. On Feb 16, 2016, Thomas D Kirby (Executive Vice President) purchased 500 shares at $26.10 per share price, according to the Form-4 filing with the securities and exchange commission.
HCP Inc. (HCP) is a real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing post-acute/skilled nursing life science medical office and hospital. Its portfolio includes owned portfolio unconsolidated joint ventures and developments and redevelopments. Its owned portfolio includes around 1040 properties under lease and 68 operating properties. It has interests in unconsolidated joint ventures representing around 88 properties in its senior housing life science and medical office segments. It has assets under development redevelopment and land held for future development in life science and medical office segments. The properties owned by it in medical office and senior housing segments which are under development or redevelopment include Pacific Corporate Park Memorial Hermann Sky Ridge Bayfront Folsom and Deer Park.